Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: +0.01% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$14M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $13M covers the $0 due within a year 13421000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2012-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2018 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $32.4M 100.0% | $26.9M 100.0% | $26.8M 100.0% | $28.1M 100.0% | $35.0M 100.0% | $26.6M 100.0% | $28.9M 100.0% | $29.3M 100.0% | $31.1M 100.0% | $32.2M 100.0% |
| Cost of Revenue | $15.3M 47.3% | $12.3M 45.8% | $11.9M 44.5% | $9.7M 34.4% | $11.8M 33.7% | $7.7M 28.8% | $6.1M 21.2% | $5.7M 19.5% | $10.8M 34.5% | $7.5M 23.4% |
| Gross Profit | $17.1M 52.7% | $14.6M 54.2% | $14.9M 55.5% | $18.5M 65.6% | $23.2M 66.3% | $19.0M 71.2% | $22.8M 78.8% | $23.6M 80.5% | $20.4M 65.5% | $24.6M 76.6% |
| Research & Development | $9.4M 29.0% | $9.8M 36.3% | $10.3M 38.4% | $10.6M 37.5% | $10.2M 29.1% | $8.1M 30.6% | $9.0M 31.2% | $8.2M 28.0% | $6.7M 21.5% | $5.5M 17.1% |
| Selling, General & Admin | $17.8M 55.1% | $17.2M 63.9% | $14.1M 52.5% | $14.4M 51.0% | $14.0M 39.9% | $6.4M 23.9% | $5.8M 20.2% | $4.9M 16.7% | $6.0M 19.2% | $10.3M 32.2% |
| Total Operating Expenses | $39.2M 121.0% | $39.3M 146.1% | $36.7M 137.1% | $37.2M 132.3% | $36.1M 103.1% | $25.7M 96.4% | $27.6M 95.5% | $26.1M 88.9% | $26.3M 84.5% | $31.1M 96.6% |
| Operating Income | -$22.1M -68.3% | -$24.7M -91.9% | -$21.8M -81.6% | -$18.8M -66.7% | -$12.9M -36.8% | -$6.7M -25.2% | -$4.8M -16.7% | -$2.5M -8.4% | -$5.9M -19.0% | -$6.4M -20.0% |
| Interest Expense | — | — | — | — | — | — | — | $17K 0.1% | $180K 0.6% | $2.5M 7.7% |
| Interest & Investment Income | — | — | — | — | $100K 0.3% | — | — | — | — | $368 0.0% |
| Other Income (Expense), net | $2K 0.0% | — | $30K 0.1% | — | — | — | — | $2.6M 8.8% | $212K 0.7% | -$2.0M -6.2% |
| Net Income | -$21.6M -66.8% | -$24.0M -89.3% | -$20.7M -77.4% | -$18.3M -65.0% | -$10.7M -30.6% | -$6.6M -25.0% | -$4.6M -15.9% | $117K 0.4% | -$5.9M -18.9% | -$5.3M -16.4% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 | $-0.11 | $-0.10 | $-0.03 | $-0.32 | $-0.54 |
| EPS (Diluted) | $-0.25 | $-0.30 | $-0.27 | $-0.26 | $-0.16 | $-0.11 | $-0.10 | $-0.03 | $-0.32 | $-0.54 |
| Weighted Avg Shares (Basic) | 91.0M | 85.2M | 80.7M | 76.1M | 75.6M | 72.7M | 63.1M | 52.1M | 22.6M | 21.8M |
| Weighted Avg Shares (Diluted) | 91.0M | 85.2M | 80.7M | 76.1M | 75.6M | 72.7M | 63.1M | 52.1M | 22.6M | 21.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 38th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 19.5 | 21.2 | 28.8 | 33.7 | 34.4 | 44.5 | 45.8 | 47.3 |
| Gross Profit | 80.5 | 78.8 | 71.2 | 66.3 | 65.6 | 55.5 | 54.2 | 52.7 |
| R&D | 28.0 | 31.2 | 30.6 | 29.1 | 37.5 | 38.4 | 36.3 | 29.0 |
| SG&A | 16.7 | 20.2 | 23.9 | 39.9 | 51.0 | 52.5 | 63.9 | 55.1 |
| Operating Income | -8.4 | -16.7 | -25.2 | -36.8 | -66.7 | -81.6 | -91.9 | -68.3 |
| Net Income | 0.4 | -15.9 | -25.0 | -30.6 | -65.0 | -77.4 | -89.3 | -66.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on STXS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.20T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.02T | 49.6× | — | 15.7× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $916.2B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $643.4B | 24.2× | — | 6.8× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $464.4B | 111.2× | 33.2× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $362.6B | 19.9× | — | 5.6× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $340.0B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $252.6B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $244.5B | 36.5× | 31.5× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $202.8B | 26.4× | 17.4× | 5.5× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $183.3B | 21.8× | 20.0× | 6.2× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.2B | 27.5× | 19.3× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $156.1B | 20.2× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $147.3B | 41.3× | 30.5× | 6.0× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $135.8B | 48.6× | 37.3× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $130.4B | 33.5× | 28.6× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $129.4B | 18.4× | — | 2.7× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.5B | 24.8× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| LGVN | $117.4B | — | — | 97924.4× | -49.9% | 67.0% | -1894% | -400% | -400% | — | 31 |
| CVS | $116.6B | 66.0× | 11.7× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $108.8B | 33.9× | 18.7× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $103.4B | 23.1× | 16.3× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.7B | 15.2× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.1B | 16.4× | 15.4× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $81.0B | 18.7× | 19.4× | 5.7× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| STXS | $120M | — | — | 3.7× | 20.3% | 52.7% | -66.8% | -161% | -161% | — | 113 |
Peers = companies sharing STXS's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.